Oral Soft Tissue ConditionsARPNCT06029322
A Comparative Clinical Study Between a Collagen Matrix and Collagen Membrane as Wound Protection During Ridge Preservation ARP
A study testing Socket seal after alveolar ridge preservation in people with Oral Soft Tissue Conditions, run by University Hospital, Ghent at 1 site in Belgium.
Trial summary
Patients in need of extraction of two teeth in combination with alveolar ridge preservation will be invited to participate in intra-subject RCT on ARP. Prior to surgery, a small-field low-dose CBCT is taken. 18 patients will be included, each contributing 1 surgical site to each treatment arm. Read more about this study
- Who is it for?
- Ages 21 years and olderHealthy volunteers can take part
- Conditions the study is for
- Oral Soft Tissue Conditions
- What is being tested?
- Socket seal after alveolar ridge preservation
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteBelgium
- Study dates
- 2 Jan 2024to 2 Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- At least 21 years old
- Good oral hygiene defined as a full-mouth plaque score ≤ 25% (O'Leary, Drake, \& Naylor, 1972)
- Need for ARP after tooth extraction at two sites in the maxilla or mandible with > 50% buccal bone present following tooth extraction
- Signed informed consent
Who cannot join
- Any systemic disease
- Pregnancy
- Smoking (will be specifically asked)
- Untreated periodontitis
- Untreated caries lesions
- Suppuration and/or active infection around the failing tooth
- Midfacial recession at the failing tooth
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Randomized Controlled Trial Comparing Collagen Matrix to Collagen Membrane as Socket Seal in Alveolar Ridge Preservation
Patients in need of extraction of two teeth in combination with alveolar ridge preservation will be invited to participate in intra-subject RCT on ARP. Prior to surgery, a small-field low-dose CBCT is taken.
18 patients will be included, each contributing 1 surgical site to each treatment arm.
Read more
Since this study is a intra-subject RCT randomization of the surgical site will be performed just after ARP by a coin flip. Randomization is concealed for the evaluating examiner and statistician.
After ARP the collagen matrix or collagen membrane is used to seal the coronal aspect of the extraction socket.
Soft tissue thickness in centre of the site will be determined using CBCT. Secondary outcomes include: Wound dimensions, socket wound healing score, changes in bone and soft tissue dimensions and changes in buccal soft tissue profile
Read the detailed description
The primary study objective is to compare soft tissue thickness in the centre of the site between collagen matrix and collagen membrane at 4 months following ARP.
Secondary study outcomes relate to the same comparison and include the following variables: wound reduction after 7 days and 21 days, socket wound healing score after 7 days, 21 days and 4 months, changes in bone and soft tissue dimensions including soft tissue profile between pre-op and 4 months.
Patients will be included in an intra-subject RCT on ARP following screening and written consent at the Department of Periodontology and Oral Implantology of the University Hospital in Ghent.
A sample size calculation was performed in SPSS Statistics 28 (IBM, New York, USA) using the paired samples t-test. The calculation was based on finding a mean difference of 0.5 mm in the final soft tissue thickness between test and control sites with a standard deviation of 0.6 mm (Eeckhout et al., 2022). With alpha set at 0.05 and a power of 0.08, the sample size calculation indicated 14 patients to be included. To compensate for possible dropouts, this number was increased to 18 patients.
Randomization, allocation concealment and blinding Since this is an intra-subject RCT, every patient receives the test treatment as well as the control treatment. A coin flip will determine which site in each patient is treated with the collagen matrix (test site) and which one with the collagen membrane (control site). Group allocation will be determined just after ARP and remains concealed for the evaluating examiner and statistician to allow for unbiased registrations and analyses, respectively.
Treatment procedures and postoperative care Patients will be instructed to take systemic antibiotics (amoxicilline 2g) and anti-inflammatory medication (ibuprofen 600 mg) 1 h pre-operatively. Just prior to the treatment, patients rinse with a 0.12% chlorhexidine solution (Perio-aid® Intensive Care, Dent-Aid Benelux, Houten, The Netherlands) and local anesthesia (Septanest special®, noradrenaline 1/100000; Septodont, Saint Maur des Fossés, France) will be administered.
Teeth are preferably extracted without flap elevation. When deemed necessary by the clinician, papillary incisions can be made for minimal reflection, which enables to place elevators without damaging soft tissues. Buccal soft tissues must never be raised. Following wound debridement and rinsing, the amount of missing bone is measured with a periodontal probe to the nearest 0.5 mm. Missing buccal bone is defined as the vertical distance between the buccal bone crest and the midfacial soft tissue margin minus 3 mm. Then, both alveolar sockets are filled with collagen-enriched deproteinized bovine bone mineral (C-DBBM, Bio-Oss Collagen® 100 mg or 250 mg, Geistlich Pharma AG, Wolhusen, Switzerland) up to the level of the lingual bone crest. The same procedure is performed for intact and non-intact alveoli. Thereupon, a coin will be flipped to determine the assignment for either one of two treatment modalities to each site:
- Test site: collagen matrix (Mucograft Seal®, Geistlich Pharma AG, Wolhusen, Switzerland)
- Control site: collagen membrane (BioGide Compressed® 13x25 mm, Geistlich Pharma AG, Wolhusen, Switzerland) At the control site a small pouch is made at the buccal and lingual aspect in order to place the membrane. The socket seal material is sutured with at least 4 single sutures (Seralon 6/0, Serag Weissner, Naila, Germany) to protect the underlying C-DBBM. Care is taken to ensure perfect approximation between the wound margins and the socket seal material.
Systemic antibiotics (amoxicilline 2g) will be continued for 4 days and anti-inflammatory medication (ibuprofen 600 mg) is taken as deemed necessary by the patient. Patients rinse with a 0.12% chlorhexidine solution twice daily for 1 week. Then, sutures are removed.
Primary outcome: soft tissue thickness in the centre of the site Soft tissue thickness in the centre of the site will be assessed using the method of Seyssens et al. (2019). A small-field low-dose CBCT image is taken at T0 (immediately postop) and T3 (4 months). All CBCT images will be obtained using a ProMax 3D Max device (Planmeca, Helsinki, Finland) with the same standardized settings (90 kV, 6.3 mA, 9 seconds, voxel size 200 μm) with a same field of view 50 × 80 mm for each patient. Lip retractors are used to clearly visualize the external soft tissue profile and patients will be instructed to fold the tongue backwards for the same reason. Using specialized software (Invivo6, Osteoid Inc., Santa Clara, California, United States), both CBCT images are superimposed. First, a reference line is drawn on the postoperative CBCT (T0) at the level of the long axis of the extracted tooth. Then, the software switch to the superimposed CBCT (T3) while keeping this reference line. Soft tissue thickness in the centre of the site will be measured on the reference line as the vertical distance between the alveolar proces and the soft tissue outline.
Bucco-lingual and mesio-distal wound dimensions These are registered with a periodontal probe to the nearest 0.5 mm at T0 (immediately postop), T1 (1 week) and T2 (3 weeks).
Socket Wound Healing Score (SWHS) SWHS (Afat et al., 2019) is assessed at T1 (1 week), T2 (3 weeks) and T3 (4 months). SWHS is used to evaluate wound dehiscence, epithelialization, quality of granulation tissue filling the post-extraction socket, and depth between early granulation tissue and wound margin. SWHS is assessed on the basis of occlusal clinical pictures and results in the following scores: 0 = Wound covered with keratinized gingiva, pink tissue color, no bleeding, continuous with healthy tissue; 1 = Socket filled with organized granulation tissue, no bleeding, collapsed to a depth of 0 - 2 mm from the buccal gingival margin; 2 = Socket filled with organized granulation tissue, ¼ to ½ of the wound showing red tissue color, no bleeding, collapsed to a depth of 2 - 4 mm from the buccal gingival margin; 3 = Socket filled with unorganized granulation tissue, more than ½ of the wound showing red tissue color, bleeding, no evidence of acute infection; 4 = Socket is filled with foreign material (food, etc.) and shows signs of alveolitis.
Changes in bone and soft tissue dimensions These will also be assessed on the same CBCT images taken at T0 (immediately postop) and T3 (4 months). Using specialized software (Invivo6, Osteoid Inc., Santa Clara, California, United States), both CBCT images are superimposed. The following reference lines will be constructed on the postoperative CBCT (T0) in the centre of the extracted tooth: the long axis of the extracted tooth, the level of the lingual bone crest perpendicular to the long axis of the extracted tooth, level -1 mm, level -3 mm and level -5 mm apical to the lingual bone crest and perpendicular to the long axis of the extracted tooth. Bone width is registered at the three levels -1, -3, and -5 mm. Buccal and lingual soft tissue height is measured as the vertical distance between the alveolar process and the soft tissue outline parallel to the vertical reference line at the most buccal and lingual part of the alveolar process. After completing all measurements on the postoperative CBCT, the software changes to the superimposed CBCT (T3) image so that the same measurements can be done while all keeping all reference lines. Finally, changes will be calculated by subtracting the measurements at T3 from the measurements at T0.
Changes in buccal soft tissue profile An intra-oral scan (Trios, 3shape, Copenhagen, Denmark) will be taken at T0 (immediately postop) and T3 (4 months). The obtained digital surface models in STL (Surface Tessellation Language) format will be imported into designated software (SMOP, Swissmeda AG, Zurich, Switzerland) to analyze profilometric changes. A study-relevant area of interest (AOI) at the buccal aspect is selected for each site. The AOI reaches from 0.5 mm below the soft tissue margin to 4 mm more apical. In mesiodistal dimension the AOI reaches from the mesial to the distal line angle. The AOI varies between sites due to individual anatomic differences but will be kept constant in each site across timepoints. Digital surface models are superimposed using the best-fit algorithm at the unchanged adjacent tooth surfaces. A mean volumetric change (mm3) within the AOI for each site from T0 to T3 is calculated by the software and divided by the AOI resulting in a mean change in buccal soft tissue profile. Details on the method can be found in an earlier paper (Eeckhout et al., 2020).
Statistical analysis SPSS Statistics 28 (IBM, New York, USA) will be used for data analysis. Mean values, standard deviations and 95% confidence intervals (CIs) will be calculated per treatment group. The paired samples t-test is used to compare test and control sites at 4 months in terms of soft tissue thickness in the centre of the site and buccal soft tissue profile.
A linear mixed model will be used to analyze the other secondary outcomes (horizontal buccal bone loss at the different levels, buccal and lingual soft tissue height, wound dimensions and SWHS). Treatment group, time, and their interaction will be modeled as fixed factors. Patient and tooth position as random factors. Estimated marginal means and 95% CIs will be calculated per treatment group and per timepoint. The level of significance is set at 0.05.
- Conditions
- Oral Soft Tissue Conditions
- Being tested
- Socket seal after alveolar ridge preservation
- Keywords
- collagen matrix, collagen membrane, alveolar ridge preservation (ARP), CBCT analysis, Volumetric analysis, peri-implant health, oral implant
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Socket seal after alveolar ridge preservationProcedure or surgery
Socket seal is performed after ARP. Using a collagen matrix or membrane the socket is sealed, at the control (membrane) site a small pouch is made at the buccal and lingual aspect. Monofilament sutures are used to secure the respective material in place.
| Study group | Role | What they receive |
|---|---|---|
| Collagen membrane | Active comparator | BioGide Compressed® 13x25 mm, Geistlich Pharma AG, Wolhusen, Switzerland Receives: Procedure: Socket seal after alveolar ridge preservation |
| collagen matrix | Experimental | Mucograft Seal®, Geistlich Pharma AG, Wolhusen, Switzerland Receives: Procedure: Socket seal after alveolar ridge preservation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Soft tissue thickness in the centre of the site
Changes in the soft tissue thickness at the centre of the site measured on CBCT
Measured: pre-op, 4 months
Secondary outcomes (3)
Socket Wound Healing Score (SWHS)
SWHS is used to evaluate wound dehiscence, epithelialization, quality of granulation tissue filling the post-extraction socket, and depth between early granulation tissue and wound margin, score 0-4
Measured: 1 week, 3 weeks, 4 months
Changes in bone and soft tissue dimensions
Changes in bone and soft tissue dimensions measured on CBCT images
Measured: 4 months
Changes in buccal soft tissue profile
Changes in buccal soft tissue profile measured by superimposing STL files using intra-oral scanners
Measured: pre-op, 4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Sep 2023
- Study start2 Jan 2024
- Primary completion2 Aug 2025
- Study completion2 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Oral Soft Tissue ConditionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Split-mouth design, intra-subject RCT Patients receive both treatments: collagen matrix and collagen membranes
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 18 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06029322
- Sponsor's protocol ID
- ONZ-2023-0516
- Acronym
- ARP
- Status last verified
- Sep 2025
- First submitted
- 31 Aug 2023
- Last updated
- 15 Sep 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: If the data can be included in a meta-analysis upon request by the authors, they can be transferred
Publications
Afat IM, Akdogan ET, Gonul O. Effects of leukocyte- and platelet-rich fibrin alone and combined with hyaluronic acid on early soft tissue healing after surgical extraction of impacted mandibular third molars: A prospective clinical study. J Craniomaxillofac Surg. 2019 Feb;47(2):280-286. doi: 10.1016/j.jcms.2018.11.023. Epub 2018 Dec 3.
PubMed 30579747Avila-Ortiz G, Chambrone L, Vignoletti F. Effect of alveolar ridge preservation interventions following tooth extraction: A systematic review and meta-analysis. J Clin Periodontol. 2019 Jun;46 Suppl 21:195-223. doi: 10.1111/jcpe.13057.
PubMed 30623987Eeckhout C, Bouckaert E, Verleyen D, De Bruyckere T, Cosyn J. A 3-Year Prospective Study on a Porcine-Derived Acellular Collagen Matrix to Re-Establish Convexity at the Buccal Aspect of Single Implants in the Molar Area: A Volumetric Analysis. J Clin Med. 2020 May 22;9(5):1568. doi: 10.3390/jcm9051568.
PubMed 32455863Martins JR, Wagner TP, Vallim AC, Konflanz W, Schwendicke F, Celeste RK, Haas AN. Comparison of the efficacy of different techniques to seal the alveolus during alveolar ridge preservation: Meta-regression and network meta-analysis. J Clin Periodontol. 2022 Jul;49(7):694-705. doi: 10.1111/jcpe.13628. Epub 2022 Apr 29.
PubMed 35451071O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972 Jan;43(1):38. doi: 10.1902/jop.1972.43.1.38. No abstract available.
PubMed 4500182Seyssens L, Eghbali A, Christiaens V, De Bruyckere T, Doornewaard R, Cosyn J. A one-year prospective study on alveolar ridge preservation using collagen-enriched deproteinized bovine bone mineral and saddle connective tissue graft: A cone beam computed tomography analysis. Clin Implant Dent Relat Res. 2019 Oct;21(5):853-861. doi: 10.1111/cid.12843. Epub 2019 Aug 28.
PubMed 31456345Tonetti MS, Cortellini P, Graziani F, Cairo F, Lang NP, Abundo R, Conforti GP, Marquardt S, Rasperini G, Silvestri M, Wallkamm B, Wetzel A. Immediate versus delayed implant placement after anterior single tooth extraction: the timing randomized controlled clinical trial. J Clin Periodontol. 2017 Feb;44(2):215-224. doi: 10.1111/jcpe.12666. Epub 2017 Jan 31.
PubMed 27978602Surdiacourt L, Pitman J, De Keyser R, Willems W, Cosyn J. A Randomized Controlled Trial Comparing the Socket Seal Technique to Guided Bone Regeneration in Alveolar Ridge Preservation. J Esthet Restor Dent. 2026 Oct 5. doi: 10.1111/jerd.70279. Online ahead of print.
PubMed 42834617
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial Comparing Collagen Matrix to Collagen Membrane as Socket Seal in Alveolar Ridge Preservation
- ClinicalTrials.gov ID
- NCT06029322
- Acronym / sponsor ID
- ARP / ONZ-2023-0516
- Conditions
- Oral Soft Tissue Conditions
- Keywords
- collagen matrix, collagen membrane, alveolar ridge preservation (ARP), CBCT analysis, Volumetric analysis, peri-implant health, oral implant
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 18 participants (estimated)
- Lead sponsor
- University Hospital, GhentUniversity, hospital or other
- Study start
- 2 Jan 2024 (actual)
- Primary completion
- 2 Aug 2025 (actual)
- Study completion
- 2 Dec 2025 (estimated)
- First posted
- 8 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients in need of extraction of two teeth in combination with alveolar ridge preservation will be invited to participate in intra-subject RCT on ARP. Prior to surgery, a small-field low-dose CBCT is taken.
18 patients will be included, each contributing 1 surgical site to each treatment arm.
Since this study is a intra-subject RCT randomization of the surgical site will be performed just after ARP by a coin flip. Randomization is concealed for the evaluating examiner and statistician.
After ARP the collagen matrix or collagen membrane is used to seal the coronal aspect of the extraction socket.
Soft tissue thickness in centre of the site will be determined using CBCT. Secondary outcomes include: Wound dimensions, socket wound healing score, changes in bone and soft tissue dimensions and changes in buccal soft tissue profile
Detailed description
The primary study objective is to compare soft tissue thickness in the centre of the site between collagen matrix and collagen membrane at 4 months following ARP.
Secondary study outcomes relate to the same comparison and include the following variables: wound reduction after 7 days and 21 days, socket wound healing score after 7 days, 21 days and 4 months, changes in bone and soft tissue dimensions including soft tissue profile between pre-op and 4 months.
Patients will be included in an intra-subject RCT on ARP following screening and written consent at the Department of Periodontology and Oral Implantology of the University Hospital in Ghent.
A sample size calculation was performed in SPSS Statistics 28 (IBM, New York, USA) using the paired samples t-test. The calculation was based on finding a mean difference of 0.5 mm in the final soft tissue thickness between test and control sites with a standard deviation of 0.6 mm (Eeckhout et al., 2022). With alpha set at 0.05 and a power of 0.08, the sample size calculation indicated 14 patients to be included. To compensate for possible dropouts, this number was increased to 18 patients.
Randomization, allocation concealment and blinding Since this is an intra-subject RCT, every patient receives the test treatment as well as the control treatment. A coin flip will determine which site in each patient is treated with the collagen matrix (test site) and which one with the collagen membrane (control site). Group allocation will be determined just after ARP and remains concealed for the evaluating examiner and statistician to allow for unbiased registrations and analyses, respectively.
Treatment procedures and postoperative care Patients will be instructed to take systemic antibiotics (amoxicilline 2g) and anti-inflammatory medication (ibuprofen 600 mg) 1 h pre-operatively. Just prior to the treatment, patients rinse with a 0.12% chlorhexidine solution (Perio-aid® Intensive Care, Dent-Aid Benelux, Houten, The Netherlands) and local anesthesia (Septanest special®, noradrenaline 1/100000; Septodont, Saint Maur des Fossés, France) will be administered.
Teeth are preferably extracted without flap elevation. When deemed necessary by the clinician, papillary incisions can be made for minimal reflection, which enables to place elevators without damaging soft tissues. Buccal soft tissues must never be raised. Following wound debridement and rinsing, the amount of missing bone is measured with a periodontal probe to the nearest 0.5 mm. Missing buccal bone is defined as the vertical distance between the buccal bone crest and the midfacial soft tissue margin minus 3 mm. Then, both alveolar sockets are filled with collagen-enriched deproteinized bovine bone mineral (C-DBBM, Bio-Oss Collagen® 100 mg or 250 mg, Geistlich Pharma AG, Wolhusen, Switzerland) up to the level of the lingual bone crest. The same procedure is performed for intact and non-intact alveoli. Thereupon, a coin will be flipped to determine the assignment for either one of two treatment modalities to each site:
- Test site: collagen matrix (Mucograft Seal®, Geistlich Pharma AG, Wolhusen, Switzerland)
- Control site: collagen membrane (BioGide Compressed® 13x25 mm, Geistlich Pharma AG, Wolhusen, Switzerland) At the control site a small pouch is made at the buccal and lingual aspect in order to place the membrane. The socket seal material is sutured with at least 4 single sutures (Seralon 6/0, Serag Weissner, Naila, Germany) to protect the underlying C-DBBM. Care is taken to ensure perfect approximation between the wound margins and the socket seal material.
Systemic antibiotics (amoxicilline 2g) will be continued for 4 days and anti-inflammatory medication (ibuprofen 600 mg) is taken as deemed necessary by the patient. Patients rinse with a 0.12% chlorhexidine solution twice daily for 1 week. Then, sutures are removed.
Primary outcome: soft tissue thickness in the centre of the site Soft tissue thickness in the centre of the site will be assessed using the method of Seyssens et al. (2019). A small-field low-dose CBCT image is taken at T0 (immediately postop) and T3 (4 months). All CBCT images will be obtained using a ProMax 3D Max device (Planmeca, Helsinki, Finland) with the same standardized settings (90 kV, 6.3 mA, 9 seconds, voxel size 200 μm) with a same field of view 50 × 80 mm for each patient. Lip retractors are used to clearly visualize the external soft tissue profile and patients will be instructed to fold the tongue backwards for the same reason. Using specialized software (Invivo6, Osteoid Inc., Santa Clara, California, United States), both CBCT images are superimposed. First, a reference line is drawn on the postoperative CBCT (T0) at the level of the long axis of the extracted tooth. Then, the software switch to the superimposed CBCT (T3) while keeping this reference line. Soft tissue thickness in the centre of the site will be measured on the reference line as the vertical distance between the alveolar proces and the soft tissue outline.
Bucco-lingual and mesio-distal wound dimensions These are registered with a periodontal probe to the nearest 0.5 mm at T0 (immediately postop), T1 (1 week) and T2 (3 weeks).
Socket Wound Healing Score (SWHS) SWHS (Afat et al., 2019) is assessed at T1 (1 week), T2 (3 weeks) and T3 (4 months). SWHS is used to evaluate wound dehiscence, epithelialization, quality of granulation tissue filling the post-extraction socket, and depth between early granulation tissue and wound margin. SWHS is assessed on the basis of occlusal clinical pictures and results in the following scores: 0 = Wound covered with keratinized gingiva, pink tissue color, no bleeding, continuous with healthy tissue; 1 = Socket filled with organized granulation tissue, no bleeding, collapsed to a depth of 0 - 2 mm from the buccal gingival margin; 2 = Socket filled with organized granulation tissue, ¼ to ½ of the wound showing red tissue color, no bleeding, collapsed to a depth of 2 - 4 mm from the buccal gingival margin; 3 = Socket filled with unorganized granulation tissue, more than ½ of the wound showing red tissue color, bleeding, no evidence of acute infection; 4 = Socket is filled with foreign material (food, etc.) and shows signs of alveolitis.
Changes in bone and soft tissue dimensions These will also be assessed on the same CBCT images taken at T0 (immediately postop) and T3 (4 months). Using specialized software (Invivo6, Osteoid Inc., Santa Clara, California, United States), both CBCT images are superimposed. The following reference lines will be constructed on the postoperative CBCT (T0) in the centre of the extracted tooth: the long axis of the extracted tooth, the level of the lingual bone crest perpendicular to the long axis of the extracted tooth, level -1 mm, level -3 mm and level -5 mm apical to the lingual bone crest and perpendicular to the long axis of the extracted tooth. Bone width is registered at the three levels -1, -3, and -5 mm. Buccal and lingual soft tissue height is measured as the vertical distance between the alveolar process and the soft tissue outline parallel to the vertical reference line at the most buccal and lingual part of the alveolar process. After completing all measurements on the postoperative CBCT, the software changes to the superimposed CBCT (T3) image so that the same measurements can be done while all keeping all reference lines. Finally, changes will be calculated by subtracting the measurements at T3 from the measurements at T0.
Changes in buccal soft tissue profile An intra-oral scan (Trios, 3shape, Copenhagen, Denmark) will be taken at T0 (immediately postop) and T3 (4 months). The obtained digital surface models in STL (Surface Tessellation Language) format will be imported into designated software (SMOP, Swissmeda AG, Zurich, Switzerland) to analyze profilometric changes. A study-relevant area of interest (AOI) at the buccal aspect is selected for each site. The AOI reaches from 0.5 mm below the soft tissue margin to 4 mm more apical. In mesiodistal dimension the AOI reaches from the mesial to the distal line angle. The AOI varies between sites due to individual anatomic differences but will be kept constant in each site across timepoints. Digital surface models are superimposed using the best-fit algorithm at the unchanged adjacent tooth surfaces. A mean volumetric change (mm3) within the AOI for each site from T0 to T3 is calculated by the software and divided by the AOI resulting in a mean change in buccal soft tissue profile. Details on the method can be found in an earlier paper (Eeckhout et al., 2020).
Statistical analysis SPSS Statistics 28 (IBM, New York, USA) will be used for data analysis. Mean values, standard deviations and 95% confidence intervals (CIs) will be calculated per treatment group. The paired samples t-test is used to compare test and control sites at 4 months in terms of soft tissue thickness in the centre of the site and buccal soft tissue profile.
A linear mixed model will be used to analyze the other secondary outcomes (horizontal buccal bone loss at the different levels, buccal and lingual soft tissue height, wound dimensions and SWHS). Treatment group, time, and their interaction will be modeled as fixed factors. Patient and tooth position as random factors. Estimated marginal means and 95% CIs will be calculated per treatment group and per timepoint. The level of significance is set at 0.05.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Split-mouth design, intra-subject RCT Patients receive both treatments: collagen matrix and collagen membranes
| Arm | Type | Receives |
|---|---|---|
| Collagen membrane | Active comparator | Procedure: Socket seal after alveolar ridge preservationBioGide Compressed® 13x25 mm, Geistlich Pharma AG, Wolhusen, Switzerland |
| collagen matrix | Experimental | Procedure: Socket seal after alveolar ridge preservationMucograft Seal®, Geistlich Pharma AG, Wolhusen, Switzerland |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- At least 21 years old
- Good oral hygiene defined as a full-mouth plaque score ≤ 25% (O'Leary, Drake, \& Naylor, 1972)
- Need for ARP after tooth extraction at two sites in the maxilla or mandible with > 50% buccal bone present following tooth extraction
- Signed informed consent
Key exclusion criteria (7 listed)
- Any systemic disease
- Pregnancy
- Smoking (will be specifically asked)
- Untreated periodontitis
- Untreated caries lesions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Socket seal after alveolar ridge preservationSocket seal is performed after ARP. Using a collagen matrix or membrane the socket is sealed, at the control (membrane) site a small pouch is made at the buccal and lingual aspect. Monofilament sutures are used to secure the respective material in place. | Procedure or surgery | Collagen membrane, collagen matrix |
Primary outcome
Soft tissue thickness in the centre of the site
Time frame: pre-op, 4 months
Changes in the soft tissue thickness at the centre of the site measured on CBCT
3 secondary outcomes
Socket Wound Healing Score (SWHS)
Time frame: 1 week, 3 weeks, 4 months
Changes in bone and soft tissue dimensions
Time frame: 4 months
Changes in buccal soft tissue profile
Time frame: pre-op, 4 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2025.
- Background: PubMed 30579747Afat IM, Akdogan ET, Gonul O. Effects of leukocyte- and platelet-rich fibrin alone and combined with hyaluronic acid on early soft tissue healing after surgical extraction of impacted mandibular third molars: A prospective clinical study. J Craniomaxillofac Surg. 2019 Feb;47(2):280-286. doi: 10.1016/j.jcms.2018.11.023. Epub 2018 Dec 3.
- Background: PubMed 30623987Avila-Ortiz G, Chambrone L, Vignoletti F. Effect of alveolar ridge preservation interventions following tooth extraction: A systematic review and meta-analysis. J Clin Periodontol. 2019 Jun;46 Suppl 21:195-223. doi: 10.1111/jcpe.13057.
- Background: PubMed 32455863Eeckhout C, Bouckaert E, Verleyen D, De Bruyckere T, Cosyn J. A 3-Year Prospective Study on a Porcine-Derived Acellular Collagen Matrix to Re-Establish Convexity at the Buccal Aspect of Single Implants in the Molar Area: A Volumetric Analysis. J Clin Med. 2020 May 22;9(5):1568. doi: 10.3390/jcm9051568.
- Background: PubMed 35451071Martins JR, Wagner TP, Vallim AC, Konflanz W, Schwendicke F, Celeste RK, Haas AN. Comparison of the efficacy of different techniques to seal the alveolus during alveolar ridge preservation: Meta-regression and network meta-analysis. J Clin Periodontol. 2022 Jul;49(7):694-705. doi: 10.1111/jcpe.13628. Epub 2022 Apr 29.
- Background: PubMed 4500182O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972 Jan;43(1):38. doi: 10.1902/jop.1972.43.1.38. No abstract available.
- Background: PubMed 31456345Seyssens L, Eghbali A, Christiaens V, De Bruyckere T, Doornewaard R, Cosyn J. A one-year prospective study on alveolar ridge preservation using collagen-enriched deproteinized bovine bone mineral and saddle connective tissue graft: A cone beam computed tomography analysis. Clin Implant Dent Relat Res. 2019 Oct;21(5):853-861. doi: 10.1111/cid.12843. Epub 2019 Aug 28.
- Background: PubMed 27978602Tonetti MS, Cortellini P, Graziani F, Cairo F, Lang NP, Abundo R, Conforti GP, Marquardt S, Rasperini G, Silvestri M, Wallkamm B, Wetzel A. Immediate versus delayed implant placement after anterior single tooth extraction: the timing randomized controlled clinical trial. J Clin Periodontol. 2017 Feb;44(2):215-224. doi: 10.1111/jcpe.12666. Epub 2017 Jan 31.
- Derived from this study: PubMed 42834617Surdiacourt L, Pitman J, De Keyser R, Willems W, Cosyn J. A Randomized Controlled Trial Comparing the Socket Seal Technique to Guided Bone Regeneration in Alveolar Ridge Preservation. J Esthet Restor Dent. 2026 Oct 5. doi: 10.1111/jerd.70279. Online ahead of print.
- Individual participant dataSharing planned: Undecided. If the data can be included in a meta-analysis upon request by the authors, they can be transferred
Related trials for Oral Soft Tissue Conditions
Not yet recruiting
Buccal Periosteal Inversion Flap vs Buccal Advancement Flap for Acute Oro-Antral Communication Closure
Acute Oroantral Communication
Not yet recruitingPhase 3
Naproxen Versus Placebo as Adjunct Treatment of Cellulitis
Cellulitis, Skin Disease, Infectious
Active, not recruitingPhase 1/2
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Solid Tumors, CNS Tumors
Active, not recruitingPhase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Advanced Breast Carcinoma, Advanced Colon Carcinoma
RecruitingObservational study
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Cancer Risk, Cancer Predisposition Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Socket seal after alveolar ridge preservation in people with Oral Soft Tissue Conditions, run by University Hospital, Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Soft tissue thickness in the centre of the site (time frame: pre-op, 4 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06029322, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.